Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 06:56:40 UTC |
---|
Update Date | 2021-09-26 23:01:09 UTC |
---|
HMDB ID | HMDB0249978 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide |
---|
Description | N-[9-(2-fluorophenyl)-12-oxo-1,10-diazatricyclo[6.4.1.0⁴,¹³]trideca-4(13),5,7,9-tetraen-11-yl]-1H-indole-2-carboximidic acid belongs to the class of organic compounds known as n-acyl-alpha amino acids and derivatives. N-acyl-alpha amino acids and derivatives are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom. Based on a literature review very few articles have been published on N-[9-(2-fluorophenyl)-12-oxo-1,10-diazatricyclo[6.4.1.0⁴,¹³]trideca-4(13),5,7,9-tetraen-11-yl]-1H-indole-2-carboximidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-[(3r)-1-(2-fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1h-indole-2-carboxamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | FC1=CC=CC=C1C1=NC(NC(=O)C2=CC3=CC=CC=C3N2)C(=O)N2CCC3=CC=CC1=C23 InChI=1S/C26H19FN4O2/c27-19-10-3-2-8-17(19)22-18-9-5-7-15-12-13-31(23(15)18)26(33)24(29-22)30-25(32)21-14-16-6-1-4-11-20(16)28-21/h1-11,14,24,28H,12-13H2,(H,30,32) |
---|
Synonyms | Value | Source |
---|
N-[9-(2-Fluorophenyl)-12-oxo-1,10-diazatricyclo[6.4.1.0,]trideca-4(13),5,7,9-tetraen-11-yl]-1H-indole-2-carboximidate | Generator |
|
---|
Chemical Formula | C26H19FN4O2 |
---|
Average Molecular Weight | 438.462 |
---|
Monoisotopic Molecular Weight | 438.149204031 |
---|
IUPAC Name | N-[9-(2-fluorophenyl)-12-oxo-1,10-diazatricyclo[6.4.1.0^{4,13}]trideca-4,6,8(13),9-tetraen-11-yl]-1H-indole-2-carboxamide |
---|
Traditional Name | N-[9-(2-fluorophenyl)-12-oxo-1,10-diazatricyclo[6.4.1.0^{4,13}]trideca-4,6,8(13),9-tetraen-11-yl]-1H-indole-2-carboxamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | FC1=CC=CC=C1C1=NC(NC(=O)C2=CC3=CC=CC=C3N2)C(=O)N2CCC3=CC=CC1=C23 |
---|
InChI Identifier | InChI=1S/C26H19FN4O2/c27-19-10-3-2-8-17(19)22-18-9-5-7-15-12-13-31(23(15)18)26(33)24(29-22)30-25(32)21-14-16-6-1-4-11-20(16)28-21/h1-11,14,24,28H,12-13H2,(H,30,32) |
---|
InChI Key | WKJDXKWFGJWGAS-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as n-acyl-alpha amino acids and derivatives. N-acyl-alpha amino acids and derivatives are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | N-acyl-alpha amino acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - N-acyl-alpha amino acid or derivatives
- Indolecarboxylic acid derivative
- Indolecarboxamide derivative
- Benzodiazepine
- 1,4-benzodiazepine
- Indole
- Indole or derivatives
- 2-heteroaryl carboxamide
- Pyrrole-2-carboxamide
- Pyrrole-2-carboxylic acid or derivatives
- Halobenzene
- Fluorobenzene
- Aryl fluoride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Substituted pyrrole
- Heteroaromatic compound
- Pyrrole
- Tertiary carboxylic acid amide
- Carboxamide group
- Ketimine
- Secondary carboxylic acid amide
- Lactam
- Propargyl-type 1,3-dipolar organic compound
- Organic 1,3-dipolar compound
- Organoheterocyclic compound
- Azacycle
- Organic nitrogen compound
- Organohalogen compound
- Imine
- Organofluoride
- Organonitrogen compound
- Organooxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2[NH]1)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O | 3853.0 | Semi standard non polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2[NH]1)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O | 3629.9 | Standard non polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2[NH]1)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O | 5433.5 | Standard polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TMS,isomer #2 | C[Si](C)(C)N1C(C(=O)NC2N=C(C3=CC=CC=C3F)C3=CC=CC4=C3N(CC4)C2=O)=CC2=CC=CC=C21 | 3958.3 | Semi standard non polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TMS,isomer #2 | C[Si](C)(C)N1C(C(=O)NC2N=C(C3=CC=CC=C3F)C3=CC=CC4=C3N(CC4)C2=O)=CC2=CC=CC=C21 | 3692.0 | Standard non polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TMS,isomer #2 | C[Si](C)(C)N1C(C(=O)NC2N=C(C3=CC=CC=C3F)C3=CC=CC4=C3N(CC4)C2=O)=CC2=CC=CC=C21 | 5412.7 | Standard polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2N1[Si](C)(C)C)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O | 3874.2 | Semi standard non polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2N1[Si](C)(C)C)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O | 3693.5 | Standard non polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2N1[Si](C)(C)C)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O | 5026.0 | Standard polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2[NH]1)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O | 4051.1 | Semi standard non polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2[NH]1)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O | 3860.0 | Standard non polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2[NH]1)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O | 5412.2 | Standard polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(C(=O)NC2N=C(C3=CC=CC=C3F)C3=CC=CC4=C3N(CC4)C2=O)=CC2=CC=CC=C21 | 4102.1 | Semi standard non polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(C(=O)NC2N=C(C3=CC=CC=C3F)C3=CC=CC4=C3N(CC4)C2=O)=CC2=CC=CC=C21 | 3905.1 | Standard non polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(C(=O)NC2N=C(C3=CC=CC=C3F)C3=CC=CC4=C3N(CC4)C2=O)=CC2=CC=CC=C21 | 5394.5 | Standard polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2N1[Si](C)(C)C(C)(C)C)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O | 4161.7 | Semi standard non polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2N1[Si](C)(C)C(C)(C)C)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O | 4122.7 | Standard non polar | 33892256 | N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC2=CC=CC=C2N1[Si](C)(C)C(C)(C)C)C1N=C(C2=CC=CC=C2F)C2=CC=CC3=C2N(CC3)C1=O | 5016.8 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-006x-6733900000-ae89497d4704e6db71d2 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide 10V, Positive-QTOF | splash10-000i-0210900000-93f9b90b9a72c84ea263 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide 20V, Positive-QTOF | splash10-000i-0121900000-e26a888880919fb6293d | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide 40V, Positive-QTOF | splash10-0006-2890200000-5675e18fe54808b5d062 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide 10V, Negative-QTOF | splash10-014i-0100900000-2b1410cdbc7c57cbe9c0 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide 20V, Negative-QTOF | splash10-014i-0402900000-2b4e0c300b020242b026 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-[(3R)-1-(2-Fluorophenyl)-4-oxo-3,4,6,7-tetrahydro[1,4]diazepino[6,7,1-hi]indol-3-yl]-1H-indole-2-carboxamide 40V, Negative-QTOF | splash10-016r-1591200000-4661948d0b1372555166 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|